Name : MANSI JAIN (30Y/F)

Date : 04 Apr 2025

Test Asked : Aarogyam C Pro With Utsh, Fbs + 1 Others

Report Status: Complete Report

PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : MANSI JAIN (30Y/F) SAMPLE COLLECTED AT :

REF. BY : SELF
(212614),HEALTH CARE POINT,16/21 POCKET 4
TEST ASKED : AAROGYAM C PRO WITH UTSH,FBS,FERR SEC 2 ROHINI,110085

Report Availability Summary

Note: Please refer to the table below for status of your tests.

14 Ready 0 Ready with Cancellation 0 Processing 0 Cancelled in Lab

TEST DETAILS REPORT STATUS

FASTING BLOOD SUGAR(GLUCOSE) Ready

AAROGYAM C PRO WITH UTSH Ready

CHLORIDE Ready

HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) Ready

SODIUM Ready

TESTOSTERONE Ready

HBA PROFILE Ready

HEMOGRAM - 6 PART (DIFF) Ready

LIVER FUNCTION TESTS Ready

IRON DEFICIENCY PROFILE Ready

KIDPRO Ready

LIPID PROFILE Ready

T3-T4-USTSH Ready

VITAMIN D TOTAL AND B12 COMBO Ready

FERRITIN Ready
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : MANSI JAIN (30Y/F) SAMPLE COLLECTED AT :

REF. BY : SELF (212614),HEALTH CARE POINT,16/21 POCKET 4 SEC 2
TEST ASKED : AAROGYAM C PRO WITH UTSH,FBS,FERR ROHINI,110085

Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
COMPLETE HEMOGRAM
MEAN CORP.HEMO.CONC(MCHC) 31.3 g/dL 31.5-34.5
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 46.4 fL 39.0-46.0
DIABETES
AVERAGE BLOOD GLUCOSE (ABG) 88 mg/dL 90-120
IRON DEFICIENCY
IRON 41.3 µg/dL 50 - 170
LIPID
TC/ HDL CHOLESTEROL RATIO 2.9 Ratio 3-5
RENAL
CALCIUM 8.26 mg/dL 8.8-10.6
URIC ACID 2.92 mg/dL 3.2 - 6.1
VITAMIN
25-OH VITAMIN D (TOTAL) 13 ng/mL 30-100
VITAMINS
VITAMIN B-12 826 pg/mL 197-771

Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values,
parameter correlation and clinical interpretation, kindly refer to the same in subsequent pages.
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : MANSI JAIN (30Y/F) SAMPLE COLLECTED AT :

REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF
SEC 2 ROHINI,110085
TEST ASKED : HBA PROFILE,HEMOGRAM

TEST NAME TECHNOLOGY VALUE UNITS

HbA1c - (HPLC)
H.P.L.C 4.7 %
Bio. Ref. Interval. :

Method : Fully Automated H.P.L.C method

AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 88 mg/dL

Bio. Ref. Interval. :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values

Please correlate with clinical conditions.

Sample Collected on (SCT) :04 Apr 2025 09:00

Sample Received on (SRT) : 04 Apr 2025 16:19

Report Released on (RRT) : 04 Apr 2025 17:53
Sample Type : EDTA Whole Blood
Labcode : 0404092437/DEL46 Dr Saakshi Mittal MD(Path)
Barcode : DO474772
Page : 1 of 13
Scan QR code to verify authenticity of reported results; active for 30 days from release time.
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : MANSI JAIN (30Y/F) SAMPLE COLLECTED AT :

REF. BY : SELF (212614),HEALTH CARE POINT,16/21 POCKET 4
SEC 2 ROHINI,110085
TEST ASKED : HBA PROFILE,HEMOGRAM

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

HEMOGLOBIN SLS-Hemoglobin Method 12.5 g/dL 12.0-15.0
Hematocrit (PCV) CPH Detection 39.9 % 36.0-46.0
Total RBC HF & EI 3.98 X 10^6/µL 3.8-4.8
Mean Corpuscular Volume (MCV) Calculated 100.3 fL 83.0-101.0
Mean Corpuscular Hemoglobin (MCH) Calculated 31.4 pq 27.0-32.0
Mean Corp.Hemo. Conc (MCHC) Calculated 31.3 g/dL 31.5-34.5
Red Cell Distribution Width - SD (RDW-SD) Calculated 46.4 fL 39.0-46.0
Red Cell Distribution Width (RDW - CV) Calculated 12.4 % 11.6-14.0
RED CELL DISTRIBUTION WIDTH INDEX (RDWI) Calculated 312.5 - *Refer Note below
MENTZER INDEX Calculated 25.2 - *Refer Note below
TOTAL LEUCOCYTE COUNT (WBC) HF & FC 7.12 X 10³ / µL 4.0 - 10.0
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils Percentage Flow Cytometry 62.2 % 40-80
Lymphocytes Percentage Flow Cytometry 31 % 20-40
Monocytes Percentage Flow Cytometry 4.4 % 2-10
Eosinophils Percentage Flow Cytometry 1.8 % 1-6
Basophils Percentage Flow Cytometry 0.3 % 0-2
Immature Granulocyte Percentage (IG%) Flow Cytometry 0.3 % 0.0-0.4
Nucleated Red Blood Cells % Flow Cytometry 0.01 % 0.0-5.0
ABSOLUTE LEUCOCYTE COUNT
Neutrophils - Absolute Count Calculated 4.43 X 10³ / µL 2.0-7.0
Lymphocytes - Absolute Count Calculated 2.21 X 10³ / µL 1.0-3.0
Monocytes - Absolute Count Calculated 0.31 X 10³ / µL 0.2 - 1.0
Basophils - Absolute Count Calculated 0.02 X 10³ / µL 0.02 - 0.1
Eosinophils - Absolute Count Calculated 0.13 X 10³ / µL 0.02 - 0.5
Immature Granulocytes (IG) Calculated 0.02 X 10³ / µL 0.0-0.3
Nucleated Red Blood Cells Calculated 0.01 X 10³ / µL 0.0-0.5
PLATELET COUNT HF & EI 183 X 10³ / µL 150-410
Mean Platelet Volume (MPV) Calculated 11.1 fL 6.5-12
Platelet Distribution Width (PDW) Calculated 12.8 fL 9.6-15.2
Platelet to Large Cell Ratio (PLCR) Calculated 32.5 % 19.7-42.4
Plateletcrit (PCT) Calculated 0.2 % 0.19-0.39
Remarks : Alert!!! Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.

*Note - Mentzer index (MI), RDW-CV and RDWI are hematological indices to differentiate between Iron Deficiency Anemia (IDA) and Beta
Thalassemia Trait (BTT). MI >13, RDWI >220 and RDW-CV >14 more likely to be IDA. MI <13, RDWI <220, and RDW-CV <14 more likely
to be BTT. Suggested Clinical correlation. BTT to be confirmed with HB electrophoresis if clinically indicated.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)

Sample Collected on (SCT) : 04 Apr 2025 09:00

Sample Received on (SRT) : 04 Apr 2025 16:19

Report Released on (RRT) : 04 Apr 2025 17:53

Sample Type : EDTA Whole Blood
Labcode : 0404092437/DEL46 Dr Saakshi Mittal MD(Path)
Barcode : DO474772 Page : 2 of 13
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : MANSI JAIN SAMPLE COLLECTED AT :

REF. BY (30Y/F) (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF SEC 2 ROHINI,110085
TEST ASKED
: BLOOD SUGAR (F)

TEST NAME TECHNOLOGY VALUE UNITS

FASTING BLOOD SUGAR(GLUCOSE) PHOTOMETRY 77.49 mg/dL

Bio. Ref. Interval. :-

As per ADA Guideline: Fasting Plasma Glucose (FPG)

Normal 70 to 100 mg/dl

Prediabetes 100 mg/dl to 125 mg/dl

Diabetes 126 mg/dl or higher

Note :
The assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed ,
icteric or lipemic. The concentration of Glucose in a given specimen may vary due to differences in assay methods, calibration and
reagent specificity. For diagnostic purposes results should always be assessed in conjunction with patients medical history, clinical
findings and other findings.
Please correlate with clinical conditions.
Method:- GOD-PAP METHOD

Sample Collected on (SCT) : 04 Apr 2025 09:00

Sample Received on (SRT) : 04 Apr 2025 17:05
Report Released on (RRT) : 04 Apr 2025 18:52
Sample Type : FLUORIDE PLASMA
Labcode : 0404095554/DEL46 Dr Saakshi Mittal MD(Path)

Barcode : DT970626 Page : 3 of 13

PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : MANSI JAIN (30Y/F) SAMPLE COLLECTED AT :

REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF
SEC 2 ROHINI,110085
TEST ASKED : AAROGYAM C PRO WITH UTSH,FERRITIN

TEST NAME TECHNOLOGY VALUE UNITS

25-OH VITAMIN D (TOTAL) E.C.L.I.A 13 ng/mL

Bio. Ref. Interval. :
Deficiency : <=20 ng/ml || Insufficiency : 21-29 ng/ml
Sufficiency : >= 30 ng/ml || Toxicity : >100 ng/ml

Clinical Significance:
Vitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; both are critical for building
bone health.
Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency, nephrotic syndrome.
Increase in vitamin D total levels indicate Vitamin D intoxication.

Specifications: Precision: Intra assay (%CV):9.20%, Inter assay (%CV):8.50%

Kit Validation Reference : Holick M. Vtamin D the underappreciated D-Lightful hormone that is important for Skeletal
and cellular health Curr Opin Endocrinol Diabetes 2002:9(1)87-98.
Method : Fully Automated Electrochemiluminescence Compititive Immunoassay

VITAMIN B-12 E.C.L.I.A 826 pg/mL

Bio. Ref. Interval. :
Normal: 197-771 pg/ml

Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat, eggs and milk. It
is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath. Vitamin-B12 is used to find
out neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias. For diagnostic purpose, results should always be
assessed in conjunction with the patients medical history, clinical examination and other findings.

Specifications: Intra assay (%CV):2.6%, Inter assay (%CV):2.3 %

Kit Validation Reference : Thomas L.Clinical laborator Diagnostics : Use and Assessment of Clinical laboratory Results 1st Edition,TH
Books-Verl-Ges,1998:424-431
Method : Fully Automated Electrochemiluminescence Compititive Immunoassay
Please correlate with clinical conditions.

Sample Collected on (SCT) :04 Apr 2025 09:00

Sample Received on (SRT) : 04 Apr 2025 17:09

Report Released on (RRT) : 04 Apr 2025 20:52
Sample Type : SERUM
Labcode : 0404096158/DEL46 Dr Saakshi Mittal MD(Path)
Barcode : DF226776
Page : 4 of 13
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : MANSI JAIN (30Y/F) SAMPLE COLLECTED AT :

REF. BY : SELF (212614),HEALTH CARE POINT,16/21 POCKET 4
SEC 2 ROHINI,110085
TEST ASKED : AAROGYAM C PRO WITH UTSH,FERRITIN

TEST NAME TECHNOLOGY VALUE UNITS

HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 0.11 mg/L
Bio. Ref. Interval. :-

< 1.00 - Low Risk

1.00 - 3.00 - Average Risk
>3.00 - 10.00 - High Risk
> 10.00 - Possibly due to Non-Cardiac Inflammation

Disclaimer: Persistent unexplained elevation of HSCRP >10 should be evaluated for non-cardiovascular etiologies such as
infection , active arthritis or concurrent illness.

Clinical significance:
High sensitivity C- reactive Protein ( HSCRP) can be used as an independent risk marker for the identification of Individuals at risk
for future cardiovascular Disease. A coronary artery disease risk assessment should be based on the average of two hs-CRP
tests, ideally taken two weeks apart.

Kit Validation Reference:

1. Clinical management of laboratory date in medical practice 2003-3004, 207(2003).
2. Tietz : Textbook of Clinical Chemistry and Molecular diagnostics :Second edition :Chapter 47:Page no.1507- 1508.

Please correlate with clinical conditions.

Method:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER

Sample Collected on (SCT) : 04 Apr 2025 09:00

Sample Received on (SRT) : 04 Apr 2025 17:09
Report Released on (RRT) : 04 Apr 2025 20:52
Sample Type : SERUM
Labcode : 0404096158/DEL46 Dr Saakshi Mittal MD(Path)

Barcode : DF226776 Page : 5 of 13

PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : MANSI JAIN (30Y/F) SAMPLE COLLECTED AT :

REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4
: SELF
SEC 2 ROHINI,110085
TEST ASKED : AAROGYAM C PRO WITH UTSH,FERRITIN

TEST NAME TECHNOLOGY VALUE UNITS

IRON PHOTOMETRY 41.3 µg/dL

Bio. Ref. Interval. :
Male : 65 - 175
Female : 50 - 170
Method : Ferrozine method without deproteinization

TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 293.76 µg/dL

Bio. Ref. Interval. :
Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl
Method : Spectrophotometric Assay

% TRANSFERRIN SATURATION CALCULATED 14.06 %

Bio. Ref. Interval. :
13 - 45
Method : Derived from IRON and TIBC values

FERRITIN E.C.L.I.A 106 ng/mL

Bio. Ref. Interval. :
13 - 150
Method : Fully Automated Electrochemiluminescence Sandwich Immunoassay

UNSAT.IRON-BINDING CAPACITY(UIBC) PHOTOMETRY 252.46 µg/dL

Bio. Ref. Interval. :
162 - 368
Method : SPECTROPHOTOMETRIC ASSAY

Please correlate with clinical conditions.

Sample Collected on (SCT) :04 Apr 2025 09:00

Sample Received on (SRT) : 04 Apr 2025 17:09

Report Released on (RRT) : 04 Apr 2025 20:52
Sample Type : SERUM
Labcode : 0404096158/DEL46 Dr Saakshi Mittal MD(Path)
Barcode : DF226776
Page : 6 of 13
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : MANSI JAIN (30Y/F) SAMPLE COLLECTED AT :

REF. BY : SELF (212614),HEALTH CARE POINT,16/21 POCKET 4
SEC 2 ROHINI,110085
TEST ASKED : AAROGYAM C PRO WITH UTSH,FERRITIN

TEST NAME TECHNOLOGY VALUE UNITS

TESTOSTERONE E.C.L.I.A 56.1 ng/dL
Bio. Ref. Interval. :-

6 - 82

Clinical Significance: Clinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males.
Major causes of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,
Hypopituitarism some types of liver and kidney diseases and critical illness.

Specifications: Precision: Intra assay (%CV): 11.50 %, Inter assay (%CV): 5.70%; Sensitivity: 7 ng/dL.
Kit Validation Reference: Wilson JD Foster DW (Eds) Williams Textbook of Endocrinology 8th Edition WB Saunders Piladelphia
Pennsylvania.

Note : The Biological Reference Range mentioned is specific to the age group and gender. Kindly correlate clinically.

Please correlate with clinical conditions.

Method:- Fully Automated Electrochemiluminescence Compititive Immunoassay

Sample Collected on (SCT) : 04 Apr 2025 09:00

Sample Received on (SRT) : 04 Apr 2025 17:09
Report Released on (RRT) : 04 Apr 2025 20:52
Sample Type : SERUM
Labcode : 0404096158/DEL46 Dr Saakshi Mittal MD(Path)

Barcode : DF226776 Page : 7 of 13

PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : MANSI JAIN (30Y/F) SAMPLE COLLECTED AT :

REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4 SEC 2
: SELF
ROHINI,110085
TEST ASKED : AAROGYAM C PRO WITH UTSH,FERRITIN

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL CHOLESTEROL PHOTOMETRY 145 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 51 mg/dL 40-60
HDL / LDL RATIO CALCULATED 0.54 Ratio > 0.40
LDL CHOLESTEROL - DIRECT PHOTOMETRY 93 mg/dL < 100
TRIG / HDL RATIO CALCULATED 0.64 Ratio < 3.12
TRIGLYCERIDES PHOTOMETRY 33 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 2.9 Ratio 3-5
LDL / HDL RATIO CALCULATED 1.8 Ratio 1.5-3.5
NON-HDL CHOLESTEROL CALCULATED 94 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 6.52 mg/dL 5 - 40
Please correlate with clinical conditions.

Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
HD/LD - Derived from HDL and LDL values.
LDL - Direct Measure
TRI/H - Derived from TRIG and HDL Values
TRIG - Enzymatic, End Point
TC/H - Derived from serum Cholesterol and Hdl values
LDL/ - Derived from serum HDL and LDL Values
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Collected on (SCT) : 04 Apr 2025 09:00

Sample Received on (SRT) : 04 Apr 2025 17:09
Report Released on (RRT) : 04 Apr 2025 20:52
Sample Type : SERUM
Labcode : 0404096158/DEL46 Dr Saakshi Mittal MD(Path)

Barcode : DF226776
Page : 8 of 13
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : MANSI JAIN (30Y/F) SAMPLE COLLECTED AT :

REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4 SEC 2
: SELF
ROHINI,110085
TEST ASKED : AAROGYAM C PRO WITH UTSH,FERRITIN

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

ALKALINE PHOSPHATASE PHOTOMETRY 58 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.63 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.15 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.48 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 10.54 U/L < 38
SGOT / SGPT RATIO CALCULATED 1.21 Ratio <2
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 13.4 U/L < 31
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 11.1 U/L < 34
PROTEIN - TOTAL PHOTOMETRY 6.15 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 3.53 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 2.62 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.35 Ratio 0.9 - 2
Please correlate with clinical conditions.

Method :
ALKP - Modified IFCC method
BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
OT/PT - Derived from SGOT and SGPT values.
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Sample Collected on (SCT) : 04 Apr 2025 09:00

Sample Received on (SRT) : 04 Apr 2025 17:09
Report Released on (RRT) : 04 Apr 2025 20:52
Sample Type : SERUM
Labcode : 0404096158/DEL46 Dr Saakshi Mittal MD(Path)

Barcode : DF226776
Page : 9 of 13
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : MANSI JAIN (30Y/F) SAMPLE COLLECTED AT :

REF. BY (212614),HEALTH CARE POINT,16/21 POCKET 4 SEC 2
: SELF
ROHINI,110085
TEST ASKED : AAROGYAM C PRO WITH UTSH,FERRITIN

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

BLOOD UREA NITROGEN (BUN) PHOTOMETRY 8.1 mg/dL 7.94 - 20.07
UREA (CALCULATED) CALCULATED 17.33 mg/dL Adult : 17-43
CREATININE - SERUM PHOTOMETRY 0.55 mg/dL 0.55-1.02
UREA / SR.CREATININE RATIO CALCULATED 31.52 Ratio < 52
BUN / SR.CREATININE RATIO CALCULATED 14.73 Ratio 9:1-23:1
CALCIUM PHOTOMETRY 8.26 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 2.92 mg/dL 3.2 - 6.1
SODIUM I.S.E - INDIRECT 138 mmol/L 136 - 145
CHLORIDE I.S.E - INDIRECT 106 mmol/L 98 - 107
Please correlate with clinical conditions.

Method :
BUN - Kinetic UV Assay.
UREAC - Derived from BUN Value.
SCRE - Creatinine Enzymatic Method
UR/CR - Derived from UREA and Sr.Creatinine values.
B/CR - Derived from serum Bun and Creatinine values
CALC - Arsenazo III Method, End Point.
URIC - Uricase / Peroxidase Method
SOD - ION SELECTIVE ELECTRODE - INDIRECT
CHL - ION SELECTIVE ELECTRODE - INDIRECT

Sample Collected on (SCT) : 04 Apr 2025 09:00

Sample Received on (SRT) : 04 Apr 2025 17:09
Report Released on (RRT) : 04 Apr 2025 20:52
Sample Type : SERUM
Labcode : 0404096158/DEL46 Dr Saakshi Mittal MD(Path)

Barcode : DF226776
Page : 10 of 13
 PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : MANSI JAIN (30Y/F) SAMPLE COLLECTED AT :

(212614),HEALTH CARE POINT,16/21 POCKET 4 SEC 2
REF. BY : SELF
ROHINI,110085
TEST ASKED : AAROGYAM C PRO WITH UTSH,FERRITIN

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL TRIIODOTHYRONINE (T3) E.C.L.I.A 110 ng/dL 80-200
TOTAL THYROXINE (T4) E.C.L.I.A 8.06 µg/dL 4.8-12.7
TSH - ULTRASENSITIVE E.C.L.I.A 4.04 µIU/mL 0.54-5.30

Comments : ***
The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :

T3,T4 - Fully Automated Electrochemiluminescence Compititive Immunoassay

USTSH - Fully Automated Electrochemiluminescence Sandwich Immunoassay

Pregnancy reference ranges for TSH/USTSH :

Trimester || T3 (ng/dl) || T4 (µg/dl) || TSH/USTSH (µIU/ml)
1st || 83.9-196.6 || 4.4-11.5 || 0.1-2.5
2nd || 86.1-217.4 || 4.9-12.2 || 0.2-3.0
3rd || 79.9-186 || 5.1-13.2 || 0.3-3.5
References :
1. Carol Devilia, C I Parhon. First Trimester Pregnancy ranges for Serum TSH and Thyroid Tumor reclassified as
Benign. Acta Endocrinol. 2016; 12(2) : 242 - 243
2. Kulhari K, Negi R, Kalra DK et al. Establishing Trimester specific Reference ranges for thyroid hormones in Indian
women with normal pregnancy : New light through old window. Indian Journal of Contemporary medical research.
2019; 6(4)

Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.

Sample Collected on (SCT) : 04 Apr 2025 09:00

Sample Received on (SRT) : 04 Apr 2025 17:09
Report Released on (RRT) : 04 Apr 2025 20:52
Sample Type : SERUM
Labcode : 0404096158/DEL46 Dr Saakshi Mittal MD(Path)
Barcode : DF226776 Page : 11 of 13
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : MANSI JAIN (30Y/F) SAMPLE COLLECTED AT :

REF. BY : SELF (212614),HEALTH CARE POINT,16/21 POCKET 4
SEC 2 ROHINI,110085
TEST ASKED : AAROGYAM C PRO WITH UTSH,FERRITIN

TEST NAME TECHNOLOGY VALUE UNITS

EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 126 mL/min/1.73 m2
Bio. Ref. Interval. :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Please correlate with clinical conditions.

Method:- 2021 CKD EPI Creatinine Equation

~~ End of report ~~

Sample Collected on (SCT) : 04 Apr 2025 09:00

Sample Received on (SRT) : 04 Apr 2025 17:09
Report Released on (RRT) : 04 Apr 2025 20:52
Sample Type : SERUM
Labcode : 0404096158/DEL46 Dr Saakshi Mittal MD(Path)

Barcode : DF226776 Page : 12 of 13

Scan QR code to verify authenticity of reported results; active for 30 days from release time.
 CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume: (a) any liability, responsibility for any loss or damage
that may be incurred by any person as a result of presuming the meaning or contents of the report, (b) any claims
of any nature whatsoever arising from or relating to the performance of the requested tests as well as any claim for
indirect, incidental or consequential damages. The total liability, in any case, of Thyrocare shall not exceed the
total amount of invoice for the services provided and paid for.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc

EXPLANATIONS

v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

SUGGESTIONS

v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints, clinical support or feedback, write to us at customersupport@thyrocare.com
or call us on 022-3090 0000

+ T&C Apply, #As on 5th December 2024, *As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)

Page : 13 of 13